Advances in Global Health: Commercializing Medical Technologies that Address Global Challenges

Highlight Preview

• Identifying clinical needs that vary across geographies
• Developing context appropriate technologies with the end-user in mind
• Securing funding for globally focused medical technologies
• Implementing solutions in varying medical environments

When:
July 7, 2021
12 – 2 PM (EDT)

Where:
Online
United States

Contact:
William Munger
wmunger@mdgboston.org
617-620-4161

The Global Health Market is large and expanding–spending could reach over $10 Trillion by 2022.

(Source: PolicyAdvice )

There are numerous, diverse clinical needs that vary by geography.

Our panelists will share their knowledge, experience, and insights in identifying unmet needs globally and navigating product development.

This is a great Forum to better understand opportunities and challenges around the globe.

Our panel of experts will cover:

• Identifying clinical needs that vary across geographies
• Developing context appropriate technologies with the end-user in mind
• Securing funding for globally focused medical technologies
• Implementing solutions in varying medical environments

Wed, July 7
12:00 – 2:00 PM (EST)
12:00 – 12:30 General Networking
12:30 – 1:30 Panelist Forum
1:30 – 2:00+ ‘Meet the Speakers’ & More Networking

Forum Fees
$0 – FREE

Join us early to network (12:00-12:30 PM), watch the Forum (12:30-1:30), then meet with them yourself in our post-Forum Networking session (1:30-2:00+)

Teresa Lopez
Clinical Ultrasound Product Specialist, Butterfly Network, Inc

Teresa Lopez is a Registered Diagnostic Medical Sonographer and combines it with her professional skills to provide better solutions for the patient, physician, clinical, and technical staff experiences.

Amy Wilkinson, RDMS RSMSK
Director of Clinical Marketing,
Butterfly Network, Inc

Amy is an Aussie-trained clinical ultrasound specialist who was recruited to the Hospital for Special Surgery in 2005 for her expertise in musculoskeletal imaging. She brings clinical understanding and market insights to the Butterfly Network to support their mission of expanding global accessibility to imaging.

Evan Noch, PhD, MD
Asst. Professor of Neurology at Weill Cornell Medicine;
Member, Board of Directors, American Physician Scientists Association

Evan is the co-inventor of DeStroke, a mobile stroke detection app. His research focuses on the molecular mechanisms of endogenous tumor-associated necrosis in glioblastoma and the regulation of glucose metabolism using targeted therapies and dietary strategies to treat glioblastoma.

Archil Bakuradze, MBA
Executive Chairman, Crystal Fund; Financier & Entrepreneur;
Fellow of the John Smith Trust (2000)

Archil leads JSC MFO Crystal, the Republic of Georgia’s largest source of microfunding. He served as Chairman of the Georgian Microfinance Association and remains on its board. He also serves on the boards of other nonprofits. He is a recipient of the international van Heuven Goedhart award from the Dutch Refugee Foundation, Stichting Vluchteling (2003).

Megan Queen Cantwell – Forum Co-Champion & Co-Moderator
Founder and President
MQC Consulting, LLC

Megan Queen Cantwell is the founder of MQC Consulting, LLC, a strategic planning and proposal development consulting firm based in Pittsburgh, PA. She has worked since 1999 in program management and project development for state and federal agencies, community organizations, and colleges and universities, with an emphasis on underserved and first-time applicants for grant funding.

Nikita Yadunath – Forum Co-Champion & Co-Moderator
Systems Verification Lead
Butterfly Network, Inc

Nikita Yadunath works as a System Verification Lead with the Design Quality team of Butterfly Network, Inc. Her background in Biomedical and Electronics engineering allows her to contribute to the medical device development process and is the foundation for her passion for medical devices. She has worked on various imaging research projects through her undergraduate and graduate study and has since worked on class II and class III medical devices.